Palonoklin 0.25 Injection 5 ml

Palonoklin 0.25 Injection 5 ml belongs to a class of drugs called antiemetics used to prevent nausea and vomiting during chemotherapy. Nausea is a feeling of uneasiness of the stomach that often comes before vomiting. On the other hand, vomiting is the forcible voluntary or involuntary emptying of stomach contents through the mouth.

Palonoklin 0.25 Injection 5 ml contains Palonosetron which works by blocking the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting.

Palonoklin 0.25 Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, you may experience diarrhoea, constipation, dizziness or headache. Most of these side effects of Palonoklin 0.25 Injection 5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Palonoklin 0.25 Injection 5 ml or any other medicines, please tell your doctor. Palonoklin 0.25 Injection 5 ml may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Palonoklin 0.25 Injection 5 ml. Drive only if you are alert as Palonoklin 0.25 Injection 5 ml may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.

Palonoklin 0.25 Injection 5 ml is used in the treatment of Nausea and vomiting. The detailed uses of Palonoklin 0.25 Injection 5 ml are as follows:

• Chemotherapy-Induced Nausea and Vomiting (CINV): Palonoklin 0.25 Injection 5 ml prevents acute and delayed CINV, providing long-lasting relief and improving patient quality of life during chemotherapy.
• Postoperative Nausea and Vomiting (PONV): Palonoklin 0.25 Injection 5 ml prevents PONV, reducing patient discomfort and promoting smoother recovery after surgery.

• Palonoklin 0.25 Injection 5 ml is administered only in clinical settings by healthcare professionals, usually through intravenous or intramuscular injections.
• The dosage and timing are decided by the doctor, depending on the cause and severity of symptoms.
• Do not self-administer this medication.
• Patients are monitored during and after administration to ensure safety and effective control of symptoms.

Palonoklin 0.25 Injection 5 ml contains Palonosetron which blocks the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting during chemotherapy.

If you are allergic to Palonoklin 0.25 Injection 5 ml or any other medicines, please tell your doctor. Palonoklin 0.25 Injection 5 ml may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Palonoklin 0.25 Injection 5 ml. Drive only if you are alert as Palonoklin 0.25 Injection 5 ml may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.